Cadex Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Cadex Genomics's estimated annual revenue is currently $620k per year.
- Cadex Genomics's estimated revenue per employee is $155,000
Employee Data
- Cadex Genomics has 4 Employees.
- Cadex Genomics grew their employee count by -43% last year.
Cadex Genomics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CHIEF SCIENCE OFFICER | Reveal Email/Phone |
Cadex Genomics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $79.4M | 512 | 0% | N/A | N/A |
#2 | $1.1M | 7 | 0% | N/A | N/A |
#3 | $2.5M | 16 | 33% | N/A | N/A |
#4 | $5M | 32 | 14% | N/A | N/A |
#5 | $1.1M | 7 | 17% | N/A | N/A |
#6 | $6M | 39 | 3% | N/A | N/A |
#7 | $3.4M | 22 | -8% | N/A | N/A |
#8 | $0.3M | 4 | 0% | N/A | N/A |
#9 | $7.4M | 48 | 50% | N/A | N/A |
#10 | $5.7M | 37 | 0% | N/A | N/A |
What Is Cadex Genomics?
Cadex Genomics develops molecular diagnostic tests to guide cancer treatment using liquid-based technology to provide personalized insight into the therapy response. By combining proven approaches to measuring DNA with cutting-edge technology to improve accuracy and sensitivity Cadex Genomics provides unique insight into therapy response using simple blood draws. Alibrex is a blood-based assay, developed to help physicians identify patients who are not responding to drug therapy. The test is optimized to maximize NPV, that is, minimize the number of false non-responders.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
-43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in St. Louis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.3M | 4 | N/A | N/A |
#2 | $0.3M | 4 | 0% | N/A |
#3 | $0.4M | 4 | N/A | N/A |
#4 | $0.3M | 4 | 0% | N/A |
#5 | $0.1M | 4 | -33% | N/A |